Fixed drug eruption by etoricoxib confirmed by patch test

14Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Non-steroidal, anti-inflammatory drugs, followed by antibiotics, are the main causes of fixed drug eruption. They provoke one or several round erythematous or bullous lesions that recur in the same place after taking the causative medication. A positive patch test on residual, lesional skin can replace satisfactorily oral reintroduction. We describe the case of a 74- year- old woman with numerous, rounded, erythematous lesions on the trunk and recurrent blistering on the fifth right-hand finger, which developed a few hours after taking etoricoxib. Lesional patch testing with etoricoxib was positive and reproduced the typical pattern of a fixed drug eruption upon histopathology. We emphasize the specific reactivity of the etoricoxib patch test, and the capacity to reproduce the histologic pattern of the reaction.

Author supplied keywords

Cite

CITATION STYLE

APA

De Sousa, A. S., Gouveia, M. P., Teixeira, V. B., Cardoso, J. C., Gameiro, A. R., & Gonçalo, M. (2016). Fixed drug eruption by etoricoxib confirmed by patch test. Anais Brasileiros de Dermatologia, 91(5), 652–654. https://doi.org/10.1590/abd1806-4841.20164301

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free